The Molecular Cytogenetics Core provides MSKCC investigators with effective chromosome-based analysis for both human and research animal cells and provides valuable support to investigators focused on understanding chromosomal instability in cancer, documentation of cell line identity and chromosomal integrity following genetic manipulations. The Molecular Cytogenetics Core processes samples from primary cells, cell lines, or archival tissue. The Core performs chromosome analysis on research samples, using conventional cytogenetics (chromosome banding and karyotyping) and molecular cytogenetics procedures based on fluorescence in situ hybridization (FISH), including Spectral Karyotyping. Staff assist investigators in designing the most appropriate and efficient analyses for their needs and produce customized probes for specific projects. The Core has assembled a broad range of molecular cytogenetics resources, including locus-specific plasmid and BAC done stocks, and individual whole chromosome painting probes. For example, the Massague lab examined the molecular basis of the link between metastasis and chemoresistance. Cancer cells that overexpress CXCL1/2 were examined. The Core provided preparation of specific probes and performed FISH to confirm sex-mismatched mouse bone marrow engraftment (XY FISH on blood smears), and performed CXCL1/2 DNA copy analysis on tissue sections of human breast tumor and metastases (frozen, paraffin, and tissue microarray) to demonstrate copy number increase and amplification. The services and collaborative work provided by the Molecular Cytogenetics Core have supported the research of 29 investigators in the past year. During the past grant period, the work of the Core has contributed to 101 publications of researchers from 6 research programs.

Public Health Relevance

Chromosome analysis is a fundamental component of cell-based research. Tumor cells frequently have highly rearranged karyotypes and even normal cells may acquire chromosomal abnormalities after extended periods in cell culture. MSKCC investigators regularly need to examine the chromosomal status of cells in a variety of ways, from isolated DNA to whole chromosomes in live cells. The Molecular Cytogenics core provides the services and expertise to meet these needs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-49
Application #
8933671
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2015-01-01
Budget End
2015-12-31
Support Year
49
Fiscal Year
2015
Total Cost
$194,017
Indirect Cost
$84,835
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Hsin, Jing-Ping; Lu, Yuheng; Loeb, Gabriel B et al. (2018) The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types. Nat Immunol 19:1137-1145
Senders, Max L; Hernot, Sophie; Carlucci, Giuseppe et al. (2018) Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis. JACC Cardiovasc Imaging :
Rogers, Emma M; Connolly, Karen L; Nehal, Kishwer S et al. (2018) Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer. J Am Acad Dermatol 78:1119-1124
Flinn, Ian W; O'Brien, Susan; Kahl, Brad et al. (2018) Duvelisib, a novel oral dual inhibitor of PI3K-?,?, is clinically active in advanced hematologic malignancies. Blood 131:877-887
Gay, Hiram A; Oh, Jung Hun; Apte, Aditya P et al. (2018) Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer. Clin Transl Radiat Oncol 13:1-6
Touijer, Karim A; Karnes, Robert Jeffery; Passoni, Niccolo et al. (2018) Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 73:890-896
Pianko, Matthew J; Moskowitz, Alison J; Lesokhin, Alexander M (2018) Immunotherapy of Lymphoma and Myeloma: Facts and Hopes. Clin Cancer Res 24:1002-1010
Bucciarelli, Peter R; Tan, Kay See; Chudgar, Neel P et al. (2018) BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis. J Thorac Oncol 13:73-84
Yang, Annie; Baxi, Shrujal; Korenstein, Deborah (2018) ClinicalTrials.gov for Facilitating Rapid Understanding of Potential Harms of New Drugs: The Case of Checkpoint Inhibitors. J Oncol Pract 14:72-76
Mikropoulos, Christos; Selkirk, Christina G Hutten; Saya, Sibel et al. (2018) Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. Br J Cancer 118:266-276

Showing the most recent 10 out of 8799 publications